Abstract

The present study was conducted to investigate the antimicrobial susceptibility profiles of Salmonella serotypes, especially fluoroquinolone-resistant strains, recovered from clinical samples in Iran. A full electronic search using related keywords was conducted in Persian and English languages in ISI Web of Knowledge, PubMed, Scopus, Google Scholar and the Scientific Information Database (SID) search engines to find papers published between 1983 and 1 July 2019. According to the inclusion and exclusion criteria, 46 eligible articles were selected for the final analysis out of the initial 13,186 studies retrieved. The pooled prevalence of quinolone-resistant Salmonella serotypes in clinical specimens in Iran was 2.9 to ciprofloxacin and 48.1 to nalidixic acid. Additional data on antibiotic resistance was as follows: 54.3 to tetracycline, 50.6 to ceftizoxime, 50.2 to streptomycin, 37.9 to ampicillin, 36.5 to kanamycin, 33.5 to trimethoprim-sulfamethoxazole, 27.2 to chloramphenicol, 19.1 to cephalothin, 8.8 to ceftriaxone, 7.6 to cefotaxime, 7.4 to aztreonam, 7.2 to gentamicin, 7 to cefepime, 6.8 to ceftazidime, 5.8 to cefixime, 2.7 to imipenem and 2.2 to meropenem. Findings of the present study showed a rising trend of resistance to the drugs of choice for the treatment of Salmonella infections, i.e. ampicillin, chloramphenicol and trimethoprim-sulfamethoxazole in Iran. However, ciprofloxacin, third-generation cephalosporins and carbapenems are still effective antibiotics especially against multi-drug resistant strains in Iran.